The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients

Benjamin Ungar, Susan Hartzell, Daniel Lozano-Ojalvo, Sabrina Ghalili, Swaroop Bose, Alexandra K. Golant, Kathryn Tan, Yeriel D. Estrada, Giselle K. Singer, Ana B. Pavel, Paolo Cravedi, Emma Guttman-Yassky

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)571-574
Number of pages4
JournalAllergy: European Journal of Allergy and Clinical Immunology
Issue number2
StatePublished - Feb 2023


  • COVID-19
  • SARS-CoV-2
  • T cell
  • atopic dermatitis
  • dupilumab

Cite this